Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma	B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2025-11-28		NCT07254754

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Evidenze CRO	5
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea	6
Kite, A Gilead Company	27

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Clínica Universidad de Navarra	Pamplona	Spain	16
Complejo Hospitalario Universitario A Coruña	A Coruña	Spain	1
Complejo Hospitalario Universitario de Gran Canaria Dr. Negrín	Las Palmas de Gran Canaria	Spain	1
Hospital Clinic i Provincial de Barcelona	Barcelona	Spain	18
Hospital Clínico Universitario de Valencia	Valencia	Spain	17
Hospital General Universitario Gregorio Marañón	Madrid	Spain	25
Hospital General Universitario Morales Meseguer	Murcia	Spain	8
Hospital Universitari Vall d'Hebron	Barcelona	Spain	11
Hospital Universitario 12 de Octubre	Madrid	Spain	55
Hospital Universitario de Salamanca	Salamanca	Spain	9
Hospital Universitario Donostia	San Sebastián	Spain	1
Hospital Universitario Marqués de Valdecilla	Santander	Spain	40
Hospital Universitario Son Espases	Palma de Mallorca	Spain	2
Hospital Universitario Virgen del Rocío	Seville	Spain	20
Institut Català d'oncologia de L'Hospitalet	L'Hospitalet de Llobregat	Spain	1